UnitedHealth Group Incorporated UNH
- Market cap
- $336.8B
- P/E
- 24.2×
Follow UNH
UnitedHealth Group Incorporated (UNH) EV/Sales
As of 25 September 2026, UnitedHealth Group Incorporated (UNH) trades at a EV/Sales of 0.8×. Over the past ten years it has ranged from 0.6× (August 2025) to 1.8× (December 2021); the current reading is higher than 13% of that period. That is above the Healthcare Plans industry median of 0.4× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Annual
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.8× | (39.58%) |
| FY2024 | 1.3× | (10.67%) |
| FY2023 | 1.4× | (9.95%) |
| FY2022 | 1.6× | (7.57%) |
| FY2021 | 1.7× | 25.09% |
| FY2020 | 1.4× | 9.61% |
| FY2019 | 1.2× | 8.51% |
| FY2018 | 1.1× | 2.10% |
| FY2017 | 1.1× | 25.24% |
| FY2016 | 0.9× | 13.44% |
Quarterly
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.9× | 44.29% |
| Mar 2026 | 0.6× | (17.27%) |
| Dec 2025 | 0.8× | (5.69%) |
| Sep 2025 | 0.8× | 6.20% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| CNC Centene Corporation compare | 0.1× |
| MOH Molina Healthcare, Inc compare | 0.1× |
| HUM Humana Inc. compare | 0.3× |
| CI Cigna Group compare | 0.3× |
| OSCR Oscar Health, Inc. compare | 0.3× |
| CVS CVS Health Corporation compare | 0.4× |
| ELV Elevance Health, Inc. compare | 0.4× |
| UNH UnitedHealth Group Incorporated | 0.8× |
| CLOV Clover Health Investments, Corp. compare | 0.9× |
| Healthcare Plans industry median | 0.4× |
| Healthcare sector median | 3.6× |
| Market median | 2.2× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on UNH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement